23andMe to lay off more than 200 employees amid business struggles

23andMe Holding Co (ME) Q2 2024 Earnings Call Highlights: Navigating Challenges with Strategic ...

Q2 2024 23andMe Holding Co. Earnings Call

23andMe is falling apart

23andMe cuts 40% of its workforce

Struggling Genetic Testing Company 23andMe To Lay Off 40% Of Its Workforce, Discontinues All Therapeutic Programs

After its entire board resigned overnight, 23andMe will cut over 200 employees and its cancer research in an urgent bid to nurse the company back to health

23andMe cuts 40% of its workforce and discontinues therapeutics division

What’s happening with 23andMe? Mass layoffs and restructuring are the latest blow for the embattled DNA-testing company

23andMe Lays Off 40% of Staff, Shuts Drug Development Business

23andMe Reports Second Quarter Fiscal Year 2025 Financial Results

23andMe Lays Off 40% of Staff, Shuts Drug Development Business